Cargando…
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
BACKGROUND: Triple negative breast cancer (TNBC) in humans is defined by the absence of oestrogen receptor (ER), progesterone receptor (PR) and HER2 overexpression. Mammalian target of rapamycin (mTOR) is overexpressed in TNBC and it represents a potential target for the treatment of this aggressive...
Autores principales: | Maniscalco, Lorella, Millán, Yolanda, Iussich, Selina, Denina, Mauro, Sánchez-Céspedes, Raquel, Gattino, Francesca, Biolatti, Bartolomeo, Sasaki, Nobuo, Nakagawa, Takayuki, Di Renzo, Maria Flavia, de las Mulas, Juana Martín, De Maria, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637810/ https://www.ncbi.nlm.nih.gov/pubmed/23587222 http://dx.doi.org/10.1186/1746-6148-9-80 |
Ejemplares similares
-
Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
por: Ordás, Javier, et al.
Publicado: (2007) -
Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma
por: Guil-Luna, Silvia, et al.
Publicado: (2014) -
Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study
por: Papparella, Serenella, et al.
Publicado: (2022) -
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
por: Riccardo, Federica, et al.
Publicado: (2019) -
Investigating a Prognostic Factor for Canine Hepatocellular Carcinoma: Analysis of Different Histological Grading Systems and the Role of PIVKA-II
por: Maniscalco, Lorella, et al.
Publicado: (2022)